SFP
ARIA

Santa Fe Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Santa Fe Partners’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-78,820
Closed -$651K – 640
2015
Q1 		$651K Buy
78,820
+5,051
+7% +$37.3K 0.08% 370
2014
Q4 		$507K Buy
+73,769
New +$461K 0.06% 376

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Santa Fe Partners's ARIA Position: Q2 2015 in Review

Santa Fe Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2015, closing a stake of 78,820 shares — an estimated $651K sold.

Santa Fe Partners first reported a position in ARIA in Q4 2014 and held it in 2 quarters. The position peaked at $651K in Q1 2015. 177 funds tracked by Wall St. Rank hold ARIA as of Q2 2015.

  • Santa Fe Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Santa Fe Partners sold 78,820 Ariad Pharmaceuticals Inc shares in Q2 2015, an estimated $651K.
  • Santa Fe Partners first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 2 quarters.
  • Santa Fe Partners's Ariad Pharmaceuticals Inc position peaked at $651K in Q1 2015.
  • 177 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2015.

Based on Santa Fe Partners's 13F filing for Q2 2015, filed 13 Aug 2015.